He wants the backing of MPs to introduce a bill requiring universal screening for neurodiversity traits in primary schools.

Although Black men die of prostate cancer at twice the rate of the rest of U.S. males, this fact often is not known or ...

Guardant Health's Shield test shows promising results in colorectal cancer screening, enhancing early detection and patient ...

Many heart failure diagnoses occur in the emergency room or inpatient setting, according to lead study author Omar ...

Please provide your email address to receive an email when new articles are posted on . Lack of a primary care provider may hinder an individual’s ability to undergo lung cancer screening, according ...

Primary care clinicians need to do a better job of informing Black men and other patients at high risk of dying from prostate ...

Fewer than one in five U.S. primary-care physicians follow practice guidelines for all recommended colorectal cancer (CRC) screening modalities. After examining survey data from 1,266 physicians ...

Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).

Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...

The data paints a bleak picture. In the United States, suicide is the second leading cause of death among teenagers and young adults aged 15 to 24 years. Half of adolescents who committed suicide were ...

The FDA approved the Shield blood test for colorectal cancer (CRC) screening in adults ages 45 and older at average risk for the disease, Guardant Health announced. According to the company, the ...

The Endocrine Society released a clinical practice guideline for the screening, diagnosis, and treatment of primary aldosteronism.